In one paragraphArticle in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
22 authors.
Verena J DreyerInstitute of Pathology, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany.
Maureen T OnyuroInstitute of Pathology, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany.
Florian SteibInstitute of Pathology, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany.ORCID 0009-0007-9416-1508 Lars HilgersInstitute of Pathology, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany.
Lancelot SeillierInstitute of Pathology, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany.ORCID 0000-0001-6704-2422 Jana DietrichInstitute of Pathology, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany.
Steffen K MeurerInstitute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), RWTH University Hospital Aachen, 52074 Aachen, Germany.ORCID 0000-0003-0821-441X Ralf WeiskirchenInstitute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), RWTH University Hospital Aachen, 52074 Aachen, Germany.ORCID 0000-0003-3888-0931 Ulf NeumannDepartment of Surgery and Transplantation, University Hospital Essen, 45147 Essen, Germany.
Lara HeijDepartment of Surgery and Transplantation, University Hospital Essen, 45147 Essen, Germany.ORCID 0000-0002-0602-3356 Tom LueddeDepartment of Gastroenterology, Hepatology and Infectious Diseases, Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany.ORCID 0000-0002-6288-8821 Sven H LoosenDepartment of Gastroenterology, Hepatology and Infectious Diseases, Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany.ORCID 0000-0002-2799-2287 Isabella LurjeDepartment of Hepatology and Gastroenterology, Campus Charité Mitte and Campus Virchow-Klinikum, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.ORCID 0000-0002-4006-7707 Georg LurjeDepartment of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, 69120 Heidelberg, Germany.
Nadine T GaisaInstitute of Pathology, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany.
Danny JonigkInstitute of Pathology, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany.
Jan BednarschDepartment of Surgery and Transplantation, University Hospital Essen, 45147 Essen, Germany.ORCID 0000-0001-8143-6452 Nadina Ortiz BrüchleInstitute of Pathology, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany.ORCID 0000-0002-8923-2726 Funding
the START-Program of the Faculty of Medicine RWTH Aachen University 02/22 (Title of project: Epigenetic characterization of cholangiocarcinoma)
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
bile duct cancerCholangiocarcinoma (CCA)class II tumor suppressor gene (C2TSG)ITIH5ITIH5 upregulation
Identifiers
PMID39518085
PMCPMC11545166
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390